Literature DB >> 18843517

Lower airway disease in asthmatics with and without rhinitis.

Anne E Dixon1, Danielle M Raymond, Benjamin T Suratt, Lorraine M Bourassa, Charles G Irvin.   

Abstract

STUDY
OBJECTIVES: The purpose of this study was to determine if asthma with rhinitis and asthma without rhinitis represent distinct forms of disease.
DESIGN: We performed a prospective cross-sectional study. PARTICIPANTS: The study included healthy controls, participants with asthma without rhinitis, and participants with both asthma and rhinitis. Interventions We compared lung function and airway inflammation between the three groups of participants.
RESULTS: We recruited 32 participants: 12 normals, 8 asthmatics without rhinitis, and 12 with rhinitis. Compared to asthmatics with rhinitis, asthmatics without rhinitis had more severe airflow limitation (FEV(1)/FVC = 60.6% [IQR = 22.8] vs. 74.8% [IQR = 7.8] and fewer induced sputum eosinophils (2.8 [IQR = 5.8] and 9.6 [IQR = 23.8], respectively). Sputum interleukin-6 correlated inversely with lung function measured by postbronchodilator FEV(1) in the study cohort (Spearman correlation coefficient = -0.55, p < 0.01).
CONCLUSIONS: Asthmatics without rhinitis tend to have lower lung function and less eosinophilic inflammation in the lung. This small study suggests that asthmatics without rhinitis represent a distinct phenotype of asthma in which low lung function is dissociated from eosinophilic cellular inflammation, and it suggests that larger studies addressing this phenotype are warrented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843517      PMCID: PMC2826710          DOI: 10.1007/s00408-008-9119-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  39 in total

1.  Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

2.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors:  R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

3.  Diesel exhaust enhances airway responsiveness in asthmatic subjects.

Authors:  C Nordenhäll; J Pourazar; M C Ledin; J O Levin; T Sandström; E Adelroth
Journal:  Eur Respir J       Date:  2001-05       Impact factor: 16.671

4.  Factors associated with persistent airflow limitation in severe asthma.

Authors:  A ten Brinke; A H Zwinderman; P J Sterk; K F Rabe; E H Bel
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

5.  Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20).

Authors:  Jay F Piccirillo; Michael G Merritt; Michele L Richards
Journal:  Otolaryngol Head Neck Surg       Date:  2002-01       Impact factor: 3.497

6.  Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.

Authors:  G J Braunstahl; A Kleinjan; S E Overbeek; J B Prins; H C Hoogsteden; W J Fokkens
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

7.  Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis.

Authors:  M Gaga; P Lambrou; N Papageorgiou; N G Koulouris; E Kosmas; S Fragakis; C Sofios; A Rasidakis; J Jordanoglou
Journal:  Clin Exp Allergy       Date:  2000-05       Impact factor: 5.018

8.  Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants.

Authors:  W Anees; V Huggins; I D Pavord; A S Robertson; P S Burge
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

9.  Chronic sinusitis in severe asthma is related to sputum eosinophilia.

Authors:  Anneke ten Brinke; Diana C Grootendorst; Judith Th Schmidt; Francisca T De Bruïne; Mark A van Buchem; Peter J Sterk; Klaus F Rabe; Elisabeth H Bel
Journal:  J Allergy Clin Immunol       Date:  2002-04       Impact factor: 10.793

10.  Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers.

Authors:  Jūrate Staikūniene; Saulius Vaitkus; Lidija Marija Japertiene; Silvija Ryskiene
Journal:  Medicina (Kaunas)       Date:  2008       Impact factor: 2.430

View more
  11 in total

1.  Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study.

Authors:  Jan Lötvall; Linda Ekerljung; Bo Lundbäck
Journal:  Respir Res       Date:  2010-11-26

2.  IL-6 is required for airway mucus production induced by inhaled fungal allergens.

Authors:  Wendy A Neveu; Jenna B Allard; Oliver Dienz; Matthew J Wargo; Gennaro Ciliberto; Laurie A Whittaker; Mercedes Rincon
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

3.  Effect of intranasal corticosteroids on allergic airway disease in asthma.

Authors:  Anne E Dixon; Mario Castro; Lynn B Gerald; Janet T Holbrook; Robert J Henderson; Thomas B Casale; Charles G Irvin; Kendall Black; Robert A Wise; Elizabeth A Sugar
Journal:  J Allergy Clin Immunol Pract       Date:  2017-04-07

4.  Interleukin-6 as a biomarker for asthma: hype or is there something else?

Authors:  Matthew E Poynter; Charles G Irvin
Journal:  Eur Respir J       Date:  2016-10       Impact factor: 16.671

5.  Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function.

Authors:  Wendy A Neveu; Jenna L Allard; Danielle M Raymond; Lorraine M Bourassa; Stephanie M Burns; Janice Y Bunn; Charles G Irvin; David A Kaminsky; Mercedes Rincon
Journal:  Respir Res       Date:  2010-03-08

6.  Interleukin 6 SNP rs1800797 associates with the risk of adult-onset asthma.

Authors:  T K Lajunen; J J K Jaakkola; M S Jaakkola
Journal:  Genes Immun       Date:  2016-03-03       Impact factor: 2.676

7.  Systemic IL-6 and Severe Asthma.

Authors:  Brian Lipworth; Rory Chan; Chris Kuo
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

Review 8.  Role of IL-6 in asthma and other inflammatory pulmonary diseases.

Authors:  Mercedes Rincon; Charles G Irvin
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

9.  IL-17F induces IL-6 via TAK1-NFκB pathway in airway smooth muscle cells.

Authors:  Masayuki Nakajima; Mio Kawaguchi; Kyoko Ota; Junichi Fujita; Satoshi Matsukura; Shau-Ku Huang; Yuko Morishima; Yukio Ishii; Hiroaki Satoh; Tohru Sakamoto; Nobuyuki Hizawa
Journal:  Immun Inflamm Dis       Date:  2017-03-03

Review 10.  Targeting Cytokines as Evolving Treatment Strategies in Chronic Inflammatory Airway Diseases.

Authors:  Jaleesa Garth; Jarrod W Barnes; Stefanie Krick
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.